Related references
Note: Only part of the references are listed.Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody
Mickael V. Cherrier et al.
EMBO JOURNAL (2009)
Fusion Loop Peptide of the West Nile Virus Envelope Protein Is Essential for Pathogenesis and Is Recognized by a Therapeutic Cross-Reactive Human Monoclonal Antibody
Hameeda Sultana et al.
JOURNAL OF IMMUNOLOGY (2009)
Crystal Structure of Dengue Virus Type 1 Envelope Protein in the Postfusion Conformation and Its Implications for Membrane Fusion
Vinod Nayak et al.
JOURNAL OF VIROLOGY (2009)
Progress towards a dengue vaccine
Daniel P. Webster et al.
LANCET INFECTIOUS DISEASES (2009)
Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle Antigens
Wayne D. Crill et al.
PLOS ONE (2009)
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
Theodore C. Pierson et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2008)
Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus
Gregory D. Gromowski et al.
JOURNAL OF VIROLOGY (2008)
Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II
Chih-Yun Lai et al.
JOURNAL OF VIROLOGY (2008)
Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins
Shee-Mei Lok et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model
Jennifer L. Kyle et al.
VIROLOGY (2008)
Maturation of west nile virus modulates sensitivity to antibody-mediated neutralization
Steevenson Nelson et al.
PLOS PATHOGENS (2008)
The growth and potential of human antiviral monoclonal antibody therapeutics
Wayne A. Marasco et al.
NATURE BIOTECHNOLOGY (2007)
The molecular basis of antibody-mediated neutralization of West Nile virus
Theodore Oliphant et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry
J. F. L. Chin et al.
MICROBES AND INFECTION (2007)
Antibody recognition and neutralization determinants on domains I and II of West Nile virus envelope protein
Theodore Oliphant et al.
JOURNAL OF VIROLOGY (2006)
Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters
John D. Morrey et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites
Karin Stiasny et al.
JOURNAL OF VIROLOGY (2006)
Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus
LH Gould et al.
JOURNAL OF VIROLOGY (2005)
Structural basis of West Nile virus neutralization by a therapeutic antibody
GE Nybakken et al.
NATURE (2005)
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus
T Oliphant et al.
NATURE MEDICINE (2005)
Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein
DE Purdy et al.
VIROLOGY (2005)
Structure of the dengue virus envelope protein after membrane fusion
Y Modis et al.
NATURE (2004)
Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses
JS Mackenzie et al.
NATURE MEDICINE (2004)
Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses
AP Goncalvez et al.
JOURNAL OF VIROLOGY (2004)
Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein
AP Goncalvez et al.
JOURNAL OF VIROLOGY (2004)
Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes
WD Crill et al.
JOURNAL OF VIROLOGY (2004)
Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice
MJ Engle et al.
JOURNAL OF VIROLOGY (2003)
Identification of a dengue virus type 2 (DEN-2) serotype-specific B-cell epitope and detection of DEN-2-immunized animal serum samples using an epitope-based peptide antigen
HC Wu et al.
JOURNAL OF GENERAL VIROLOGY (2003)
Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus
GJJ Chang et al.
VIROLOGY (2003)
Antigenic structure of flavivirus proteins
JT Roehrig
FLAVIVIRUSES: STRUCTURE, REPLICATION AND EVOLUTION (2003)
Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion
RJ Kuhn et al.
CELL (2002)
Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes:: insight into the neutralization mechanism
P Thullier et al.
JOURNAL OF GENERAL VIROLOGY (2001)
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells
WD Crill et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
